| 000 | 01663 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516024808.0 | ||
| 264 | 0 | _c20110802 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1879-0054 | ||
| 024 | 7 |
_a10.1016/j.domaniend.2011.01.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPampusch, M S | |
| 245 | 0 | 0 |
_aLow-density lipoprotein-related receptor protein 1 (LRP-1) is not required for insulin-like growth factor binding protein 3 (IGFBP-3) to suppress L6 myogenic cell proliferation. _h[electronic resource] |
| 260 |
_bDomestic animal endocrinology _cMay 2011 |
||
| 300 |
_a197-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlotting, Western _xveterinary |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aImmunohistochemistry _xveterinary |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Protein 3 _xmetabolism |
| 650 | 0 | 4 |
_aLow Density Lipoprotein Receptor-Related Protein-1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMuscle Development |
| 650 | 0 | 4 |
_aMyoblasts _xcytology |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aSwine _xgenetics |
| 700 | 1 | _aKamanga-Sollo, E | |
| 700 | 1 | _aHathaway, M R | |
| 700 | 1 | _aWhite, M E | |
| 700 | 1 | _aDayton, W R | |
| 773 | 0 |
_tDomestic animal endocrinology _gvol. 40 _gno. 4 _gp. 197-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.domaniend.2011.01.001 _zAvailable from publisher's website |
| 999 |
_c20628472 _d20628472 |
||